TOKYO, May 20, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a holistic healthcare company based in Japan (the “Company” or “MEDIROM”), today announced that for the year ended December 31, 2024, the Company had total revenue of $52,736,000, a 22% increase over total revenue of $43,388,000 for the year ended December 31, 2023. (The Company reports its financial results in Japanese yen and figures presented in this press release in US dollars have been translated for convenie ...

TOKYO, May 19, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a holistic healthcare company based in Japan (the “Company” or “MEDIROM”) today announced that it will host a webcast to review the Company’s financial results for the fiscal year ended December 31, 2024, on Wednesday, May 21, 2025 at 8:30 am Eastern Time. The Company will issue a press release discussing those results after the market close on Tuesday, May 20th, 2025. In addition, on April 29, 2025, the Company f ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Fumitoshi Fujiwara Chief Financial Officer Telephone: +81-(0)3-6721-7364 Email: ir@medirom.co.jp 2-3-1 Daiba, Minato-ku, Tokyo 135-0091, Japan (Name, Telephone, E-mail and/or Facsimile Number and Address of Company Contact Pe ...

Core Viewpoint - MEDIROM Healthcare Technologies Inc. has secured a new unsecured short-term bank loan of JPY350 million (approximately $2.4 million) to strengthen its financial position and support the development of its Mother Bracelet product [1][2] Financial Details - The loan amount is JPY350 million, with JPY200 million allocated for repaying debts of MEDIROM Mother Labs Inc., a subsidiary and guarantor of the loan [1] - The remaining funds will be used for general working capital, including the development of the Mother Bracelet [1] - The loan carries an interest rate of 1.875% per year [1] Company Overview - MEDIROM operates 308 relaxation salons across Japan, with its leading brand being Re.Ra.Ku® [6] - The company entered the health tech sector in 2015 and launched healthcare programs using an on-demand training app called "Lav®" [6] - In 2020, MEDIROM developed a smart tracker named "MOTHER Bracelet®" and launched a remote monitoring system called REMONY in 2023 [6] - The company aims to collect and manage healthcare data to become a leader in big data within the healthcare industry [6]

Core Viewpoint - MEDIROM Healthcare Technologies Inc. has secured a new unsecured short-term bank loan of JPY350 million (approximately $2.4 million) to strengthen its financial position and support the development of its Mother Bracelet product [1][2]. Financial Summary - The loan amount is JPY350 million, with JPY200 million allocated for repaying debts of MEDIROM Mother Labs Inc., a subsidiary and guarantor of the loan [1]. - The remaining funds will be used for general working capital, including the development of the Mother Bracelet [1]. - The loan carries an interest rate of 1.875% per year [1]. Company Overview - MEDIROM operates 308 relaxation salons across Japan, with its leading brand being Re.Ra.Ku® [5]. - The company entered the health tech sector in 2015 and launched healthcare programs using an on-demand training app called "Lav®" [5]. - In 2020, MEDIROM developed a smart tracker named "MOTHER Bracelet®" and in 2023, it launched REMONY, a remote monitoring system for various industries [5]. - MEDIROM aims to leverage its diverse health-related products and services to collect and manage healthcare data, aspiring to become a leader in big data within the healthcare industry [5].

Core Insights - MEDIROM Healthcare Technologies Inc. announced a second investment by Yasuhiro Hayami, Chief Business Officer of MEDIROM Mother Labs Inc., in the Series A financing at a pre-money valuation of JPY9 billion (approximately US$60 million) [1] - This investment follows Mr. Hayami's initial investment in December 2024, indicating his commitment to the company's growth potential and alignment with MEDIROM's corporate philosophy [1] Company Overview - MEDIROM Mother Labs Inc. is a subsidiary of MEDIROM Healthcare Technologies Inc., focusing on the health-tech sector [6] - The company offers the "Specific Health Guidance Program" through the "Lav" health application and has developed the MOTHER Bracelet, a 24/7 recharge-free smart tracker [6][8] - The MOTHER Bracelet utilizes innovative technology to generate power based on temperature differences, allowing it to record key health metrics without the need for recharging [8][9] Executive Background - Yasuhiro Hayami has a diverse career, including roles as Executive Officer at transcosmos inc. and founder of Wise, Inc., before becoming the Chief Business Officer of MEDIROM Mother Labs in 2024 [2][6]

Core Insights - MEDIROM Healthcare Technologies Inc. announced a second investment by Yasuhiro Hayami, Chief Business Officer of MEDIROM Mother Labs Inc., in the Series A financing at a pre-money valuation of JPY9 billion (approximately US$60 million) [1] - This investment follows Mr. Hayami's initial investment in December 2024, indicating his commitment to the company's growth potential and alignment with MEDIROM's corporate philosophy [1] Company Overview - MEDIROM Mother Labs Inc. is a subsidiary of MEDIROM Healthcare Technologies Inc., focusing on the health-tech sector [6] - The company offers the "Specific Health Guidance Program" through the "Lav" health application and has developed the 24/7 recharge-free MOTHER Bracelet, which is a smart tracker [6][8] - The MOTHER Bracelet utilizes innovative technology to generate power based on temperature differences, allowing it to operate without recharging and recording key health metrics [8][9] Executive Background - Yasuhiro Hayami has a diverse career, including roles as Executive Officer at transcosmos inc. and founder of Wise, Inc., before becoming the Chief Business Officer of MEDIROM Mother Labs in 2024 [2][6]

Core Insights - MEDIROM Healthcare Technologies Inc. reported preliminary financial results for the year ended December 31, 2024, indicating sustained revenue growth and improved operating profitability [1][12] - The company expects total revenue of approximately JPY 8.2 billion ($52.6 million), a projected increase of JPY 1.4 billion ($9.2 million) from the previous year [5][8] - Adjusted operating income is anticipated to be around JPY 160 million ($1.0 million), marking a significant recovery from an operating loss in 2023 [5][12] Financial Performance - Total revenue for 2024 is projected at JPY 8.2 billion ($52.6 million), driven by increased sales of salons, store outsourcing revenue, and revenue from a newly acquired rehabilitation business [5][12] - Adjusted operating expenses are expected to be approximately JPY 8.12 billion ($51.6 million), reflecting an increase of JPY 0.9 billion ($5.7 million) due to higher costs associated with salon operations and professional fees [5][8] - The adjusted operating income of JPY 160 million ($1.0 million) represents a recovery of JPY 552 million ($3.5 million) from the previous year's operating loss [5][12] Key Performance Indicators - The total number of salons operated by the company was 308 as of December 2024, serving 945,395 customers throughout the year [10][20] - Average sales per customer were JPY 7,111 ($45.2), with a repeat customer ratio of 76.3% [10] - The average operation ratio stood at 45.7% for the year [10] Management Commentary - The CEO expressed satisfaction with the revenue growth and improved operating income, attributing success to the recovery from the COVID-19 pandemic and the growth in salon sales to investors [12] - The company aims to maintain its growth momentum into 2025 while completing the audit of its financial results under U.S. GAAP [12][16]

Core Insights - MEDIROM Healthcare Technologies Inc. reported updated Key Performance Indicators (KPIs) for December 2024, highlighting growth in sales per customer and overall salon performance [1][2]. Salon Operation Business - Sales per customer increased to JPY 7,384 in December 2024 from JPY 7,271 in December 2023, indicating a year-over-year growth [2]. - In December 2024, the company operated 308 salons, serving a total of 80,764 customers with a repeat customer ratio of 77.6% and an operation ratio of 45.9% [3][4]. Health Tech Business (Lav®) - The company offers a health guidance program using the Lav® app, which provides remote support to individuals at risk of lifestyle-related diseases [6][7]. - As of December 2024, MEDIROM has contracts with 97 corporate insurance associations, with a cumulative user base of 8,816 individuals utilizing the Lav® app [9][10]. Market Context - The Japanese government has set targets for specific medical checkup implementation rates at 70% and health guidance implementation rates at 45%, with current rates at 56.5% and 24.6% respectively, indicating potential market growth for health services [8].

Core Points - MEDIROM Healthcare Technologies Inc. completed its offering of 2,860,000 common shares, generating approximately $5 million in gross proceeds [1][2] - This offering is noted as the first follow-on registered underwritten public offering in the U.S. by a Japanese company listed solely on a U.S. stock exchange [2] - The proceeds from the offering will be used for working capital and general corporate purposes, including investments, acquisitions, and the development of new services [3] Company Overview - MEDIROM operates over 300 wellness salons in Japan, with its leading brand being Re.Ra.Ku®, and has expanded into health tech since 2015 [6] - The company has developed various healthcare programs and devices, including the "Lav®" training app and the "MOTHER Bracelet®" smart tracker [6] - In 2023, MEDIROM launched REMONY, a remote monitoring system for corporate clients, receiving orders from diverse industries such as nursing care and transportation [6] - The company aims to leverage its health-related products and services to collect and manage healthcare data, aspiring to become a leader in big data within the healthcare sector [6]